跳至主要内容
临床试验/NCT06743620
NCT06743620Enrolling By Invitation不适用

Prospective Observational Long-Term Safety and Effectiveness Registry of Patients Who Have Received Iltamiocel as Part of Cook Myosite, Inc. Sponsored CELLEBRATE Clinical Study in Patients With Persistent or Recurrent Stress Urinary Incontinence (SUI) Following Surgical Treatment

Cook MyoSite2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2025年4月11日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
96
试验地点
2
主要终点
Long term safety

研究概览

简要总结

The main purpose of this registry is to collect observational, long-term safety and effectiveness data in subjects who have received at least one dose of iltamiocel as part of the CLBT clinical study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Has completed participation within 15 months in the CLBT clinical study for females with persistent or recurrent SUI following surgical treatment (i.e., either subject has completed all follow-up visits or has been officially exited from the study).
  • Has received at least one dose of iltamiocel as part of the CLBT study.
  • Must be willing and able to comply with the study procedures, is able to understand all study requirements and must agree to read and sign the informed consent form prior to any study-related procedures.
  • Has access to a phone or electronic device to allow completion of electronic documents

排除标准

  • Has only received placebo as part of the CLBT study.
  • Unable or unwilling to provide informed consent.

结局指标

主要结局

Long term safety

时间窗: 5 years

Long term safety of iltamiocel

Long term effectiveness

时间窗: 5 years

Long term effectiveness of iltamiocel

次要结局

未报告次要终点

研究者

发起方
Cook MyoSite
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Observational Registry for Iltamiocel Compared to... | 临床试验